Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
investorenquiries@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • PhamAust AGM 2022
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • PhamAust AGM 2022
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Author Archives: PharmAust

PharmAust Progresses to Elevated Doses in MND Patients

News and Announcements 2023By PharmAustJanuary 20, 2023

PharmAust Progresses to Elevated Doses of MPL in MND Patients

Fireside chat with Dr Roger Aston

News and Announcements 2023By PharmAustJanuary 17, 2023

https://www.pharmaust.com/wp-content/uploads/2023/01/Fireside-chat-with-Roger.mp4

MND Trial Successfully Completes First Patient Cohort

News and Announcements 2023By PharmAustJanuary 6, 2023

MND Trial Completes Enrolment of First Patient Cohort (final)

Fireside chat with Dr Kim

News & Announcements 2022By PharmAustDecember 23, 2022

https://www.pharmaust.com/wp-content/uploads/2022/12/Fireside-chat-with-Dr-Kim-edited.mp4

PharmAust Canine Trial Update

News & Announcements 2022By PharmAustDecember 20, 2022

PharmAust canine trial update (final) clarification

PharmAust Receives R&D Tax Incentive Refund

News & Announcements 2022By PharmAustDecember 12, 2022

PharmAust Receives R&D Tax Incentive Refund

MND Trial Completes Enrolment of First Patient Cohort

News & Announcements 2022By PharmAustDecember 2, 2022

MND Trial Completes Enrolment of First Patient Cohort (final)

Morgans – PharmAust Business Summary Report

Research Notes 2022By PharmAustNovember 24, 2022

Morgans Healthcare Research – PAA

Morgans Healthcare Research – PharmAust

Research Notes 2022By PharmAustNovember 24, 2022

AUS_Healthcare

PhamAust Webinar

News & Announcements 2022By PharmAustNovember 17, 2022

https://www.pharmaust.com/wp-content/uploads/2022/11/PharmAust-Webinar.mp4

→12345…
678910111213141516171819202122232425262728293031323334353637383940414243444546
47→
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

TWITTER

PharmAust Follow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
pharmaust PharmAust @pharmaust ·
6 Feb

Reply on Twitter 1622400583046168577 Retweet on Twitter 1622400583046168577 1 Like on Twitter 1622400583046168577 7 Twitter 1622400583046168577
Retweet on Twitter PharmAust Retweeted
pharmaust PharmAust @pharmaust ·
3 Feb

Cancer trial not a cure, but could prolong Bella’s life and help other dogs
https://www.bordermail.com.au/story/8072061/cancer-trial-not-a-cure-but-could-prolong-bellas-life-and-help-other-dogs/?cs=9681

Reply on Twitter 1621640763665969152 Retweet on Twitter 1621640763665969152 3 Like on Twitter 1621640763665969152 12 Twitter 1621640763665969152
pharmaust PharmAust @pharmaust ·
3 Feb

Cancer trial not a cure, but could prolong Bella’s life and help other dogs
https://www.bordermail.com.au/story/8072061/cancer-trial-not-a-cure-but-could-prolong-bellas-life-and-help-other-dogs/?cs=9681

Reply on Twitter 1621640763665969152 Retweet on Twitter 1621640763665969152 3 Like on Twitter 1621640763665969152 12 Twitter 1621640763665969152
Load More
Copyright © 2022 PharmAust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top